According to the recent statistics released by the Brazilian Health Surveillance Agency (ANVISA), 742 medicines were registered in Brazil in 2015, a 105 percent overall increase over 2014.
Among these, there has been a 116 percent increase in the authorization of generics over 2014 and a 286 percent increase in similar drugs.
Additionally, ANVISA has reported that in 2015 a license for the marketing of drugs for the treatment of hepatitis C was granted, and the first two biosimilar drugs as well as the first vaccine against dengue were registered.
Source: http://portal.anvisa.gov.br
Previously published 28 January 2016
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
